Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Bacterin International Holdings Inc Reaffirms FY 2012 Revenue Guidance-Conference Call
Bacterin International Holdings Inc announced that for fiscal 2012, it is comfortable with the previously stated expectation of $53-$56 million revenue.
Latest Developments for Bacterin International Holdings Inc
- Bacterin International Holdings Inc Announces Board Chnages-Form 8-K
- Bacterin International Holdings Announces Transition of Executive Leadership
- Bacterin International Holdings Inc Comments On FY 2013 Earnings Guidance-Conference Call
- Bacterin International Holdings Inc Issues FY 2013 Revenue Guidance Above Analysts' Estimates-Conference Call
Latest Key Developments in Advanced
- Covidien PLC Approves Separation Of Pharmaceuticals Business And Declares Dividend Of Mallinckrodt Ordinary Shares
- Nephros Inc Announces Completion Of Rights Offering
- Volcano Corp Announces Preliminary Results From ADVISE II Study
- Nordion Inc Enters Into Agreement To Divest Targeted Therapies Business To BTG Plc
- Share this
- Link this
- Digg this
Follow Reuters